Cargando…

Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting

Detalles Bibliográficos
Autores principales: Harrow, Brooke, Fagnani, Francis, Nevoret, Camille, Truong-Thanh, Xuan-Mai, de Zélicourt, Marie, de Mestier, Louis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859832/
https://www.ncbi.nlm.nih.gov/pubmed/36315341
http://dx.doi.org/10.1007/s12325-022-02335-7
_version_ 1784874448258596864
author Harrow, Brooke
Fagnani, Francis
Nevoret, Camille
Truong-Thanh, Xuan-Mai
de Zélicourt, Marie
de Mestier, Louis
author_facet Harrow, Brooke
Fagnani, Francis
Nevoret, Camille
Truong-Thanh, Xuan-Mai
de Zélicourt, Marie
de Mestier, Louis
author_sort Harrow, Brooke
collection PubMed
description
format Online
Article
Text
id pubmed-9859832
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-98598322023-01-22 Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting Harrow, Brooke Fagnani, Francis Nevoret, Camille Truong-Thanh, Xuan-Mai de Zélicourt, Marie de Mestier, Louis Adv Ther Correction Springer Healthcare 2022-10-31 2023 /pmc/articles/PMC9859832/ /pubmed/36315341 http://dx.doi.org/10.1007/s12325-022-02335-7 Text en © Springer Healthcare Ltd., part of Springer Nature 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Correction
Harrow, Brooke
Fagnani, Francis
Nevoret, Camille
Truong-Thanh, Xuan-Mai
de Zélicourt, Marie
de Mestier, Louis
Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
title Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
title_full Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
title_fullStr Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
title_full_unstemmed Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
title_short Correction to: Patterns of Use and Clinical Outcomes with Long-Acting Somatostatin Analogues for Neuroendocrine Tumors: A Nationwide French Retrospective Cohort Study in the Real-Life Setting
title_sort correction to: patterns of use and clinical outcomes with long-acting somatostatin analogues for neuroendocrine tumors: a nationwide french retrospective cohort study in the real-life setting
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859832/
https://www.ncbi.nlm.nih.gov/pubmed/36315341
http://dx.doi.org/10.1007/s12325-022-02335-7
work_keys_str_mv AT harrowbrooke correctiontopatternsofuseandclinicaloutcomeswithlongactingsomatostatinanaloguesforneuroendocrinetumorsanationwidefrenchretrospectivecohortstudyinthereallifesetting
AT fagnanifrancis correctiontopatternsofuseandclinicaloutcomeswithlongactingsomatostatinanaloguesforneuroendocrinetumorsanationwidefrenchretrospectivecohortstudyinthereallifesetting
AT nevoretcamille correctiontopatternsofuseandclinicaloutcomeswithlongactingsomatostatinanaloguesforneuroendocrinetumorsanationwidefrenchretrospectivecohortstudyinthereallifesetting
AT truongthanhxuanmai correctiontopatternsofuseandclinicaloutcomeswithlongactingsomatostatinanaloguesforneuroendocrinetumorsanationwidefrenchretrospectivecohortstudyinthereallifesetting
AT dezelicourtmarie correctiontopatternsofuseandclinicaloutcomeswithlongactingsomatostatinanaloguesforneuroendocrinetumorsanationwidefrenchretrospectivecohortstudyinthereallifesetting
AT demestierlouis correctiontopatternsofuseandclinicaloutcomeswithlongactingsomatostatinanaloguesforneuroendocrinetumorsanationwidefrenchretrospectivecohortstudyinthereallifesetting